Geneception
3 known investors
Skyline Therapeutics develops gene therapies using an adeno-associated virus (AAV) platform that combines capsid discovery, vector engineering, process development, and GMP manufacturing. Its capDRIVE platform screens AAV capsids to identify candidates for treating rare or severe diseases, including a gene therapy for retinitis pigmentosa.
Investors · 3
Frequently asked questions
- What does Geneception do?
- Skyline Therapeutics develops gene therapies using an adeno-associated virus (AAV) platform that combines capsid discovery, vector engineering, process development, and GMP manufacturing. Its capDRIVE platform screens AAV capsids to identify candidates for treating rare or severe diseases, including a gene therapy for retinitis pigmentosa.
- Who are Geneception's investors?
- Geneception's investors include F-Prime Capital, LAV, Lilly Asia Ventures.